A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers.

about

A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers.

Item

http://www.wikidata.org/entity/Q39207675

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers.

@en

A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers.

@nl

type

Item

label

A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers.

@en

A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers.

@nl

prefLabel

A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers.

@en

A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers.

@nl

P1476

A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers.

@en

P2093

Dashzeveg Bayarsaihan

http://www.w3.org/2001/XMLSchema#string

Dong-Guk Shin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Bromodomain Inhibitor Review: Bromodomain and Extra-terminal Family Protein Inhibitors as a Potential New Therapy in Central Nervous System Tumors

The Mediator complex: a master coordinator of transcription and cell lineage development

Super-enhancers: Asset management in immune cell genomes

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain

Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression

The discovery of I-BET726 (GSK1324726A), a potent tetrahydroquinoline ApoA1 up-regulator and selective BET bromodomain inhibitor

RVX-297- a novel BD2 selective inhibitor of BET bromodomains

The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins

P304

63-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28356894

http://www.w3.org/2001/XMLSchema#string

P921

nuclear protein

transport protein

regulation of gene expression

nucleoprotein

P932

5369046

http://www.w3.org/2001/XMLSchema#string